Nancy Lurker - 15 May 2025 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
Director
Signature
/s/ Colleen Tupper as Attorney-In-Fact For Nancy Lurker
Issuer symbol
COLL
Transactions as of
15 May 2025
Net transactions value
$0
Form type
4
Filing time
19 May 2025, 17:43:15 UTC
Previous filing
14 Apr 2025
Next filing
23 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lurker Nancy Director C/O COLLEGIUM PHARMACEUTICAL, INC., 100 TECHNOLOGY CENTER DRIVE, STOUGHTON /s/ Colleen Tupper as Attorney-In-Fact For Nancy Lurker 19 May 2025 0001450485

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +9,791 +77% $0.000000 22,517 15 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.

Remarks:

Exhibit 24.1 - Power of Attorney